, Volume 65, Issue 15, pp 2147–2147 | Cite as

Palifermin in Myelotoxic Therapy-Induced Oral Mucositis

A Viewpoint by Nicole M.A. Blijlevens and Shaun McCann
  • Nicole M. A. Blijlevens
  • Shaun McCann
Adis Drug Profile Guest Commentary


Oral Mucositis Haematopoietic Stem Cell Transplantation Keratinocyte Growth Factor Epithelial Cell Apoptosis Palifermin 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


  1. 1.
    Sonis ST. The pathobiology of mucositis. Nat Rev Cancer 2004; 4(4): 277–84PubMedCrossRefGoogle Scholar
  2. 2.
    Spielberger R, Stiff P, Bensinger W, et al. Palifermin for oral mucositis after intensive therapy for hematologic cancers. N Engl J Med 2004; 351(25): 2590–8PubMedCrossRefGoogle Scholar

Copyright information

© Adis Data Information BV 2005

Authors and Affiliations

  • Nicole M. A. Blijlevens
    • 1
  • Shaun McCann
    • 2
  1. 1.Department of HaematologyUniversity Medical Centre St Radboud NijmegenNijmegenThe Netherlands
  2. 2.Department of Haematology, St James’s HospitalUniversity of DublinDublinIreland

Personalised recommendations